Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/041109
CTRI/2022/03/041109
Recruiting
未知

Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial.

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\) Age 18\-70 yrs
  • •2\) An informed consent from the patient or relative

Exclusion Criteria

  • •1\.Age \<18 years and \> 70 years
  • •3\.Severe sepsis requiring higher dose of noradrenaline ( \>1mcg/Kg/min)
  • •4\.Myocardial dysfunction, Coronary artery disease, Arrhythmias
  • •5\.Peripheral Vascular disease
  • •6\.Gut Paralysis
  • •7\.Acute on chronic liver failure (ACLF)
  • •8\.Hepato\-cellular carcinoma (HCC), intrahepatic or extrahepatic malignancy
  • •9\.Complete portal vein thrombosis
  • •10\.Hepatic vein outflow tract obstruction (HVOTO)
  • •11\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparison effect of intravenous Vasopressin versus Norepinephrine on correction of cardiac function and renal function in low cardiac out put patient after CABG in Mosavi hospital at 1394Coronary Artery Disease.Atherosclerotic heart disease
IRCT2016051023760N2Zanjan University Of Medical Sciences40
Not yet recruiting
Not Applicable
A clinical trial to study the efficiency of two drugs terlipressin and noradrenaline in patients with low blood pressure and liver failure.Health Condition 1: K768- Other specified diseases of liver
CTRI/2021/09/036920Pt BD Sharma Pgims rohtak
Completed
Not Applicable
Effects of Vasopressin in Septic ShockSeptic shock.Septic shock
IRCT2012100311002N1Tehran University of Medical Sciences30
Not yet recruiting
Not Applicable
Role of Terlipressin in maintaning blood pressure in a patient going into shock because of sepsisHealth Condition 1: R652- Severe sepsis
CTRI/2019/10/021484Hospital Supplies AIIMS Jodhpur
Not yet recruiting
Phase 2
Comparison of Terlipressin and low dose Terlipressin and noradrenalin in HRS-AKI patients of ACLFHealth Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2023/10/058546on sponsered